Fortinet (NASDAQ: FTNT) - Do Nothing - Q3 FY12/26 Earnings Review
Fortinet’s revenue rose 20% to $2.08 billion, but its 15% Q4 growth guide drove a 25% post-earnings stock drop as product, billings and services growth decelerated.
Fortinet’s revenue rose 20% to $2.08 billion, but its 15% Q4 growth guide drove a 25% post-earnings stock drop as product, billings and services growth decelerated.
Holy sht, $MRVL is in the final stages of a deal to acquire $LITE. Attempting to vertically integrate the most supply constrained chokepoints… with lasers. Is very big brain if they pull it off and suddenly makes other laser players more strategically valuable. https://t.co/61vfIIsBRw
@KrisPatel99 I didn't expect it to be off 19% but the way $NOW runs their calls seems so desperately promotional to me.
$MRVL for $LITE absolutely meets the test mentioned below. https://t.co/53nmZnoYQ9
*MARVELL IS SAID IN ADVANCED TALKS TO BUY LUMENTUM HOLDINGS What the fuck???? $MRVL $LITE
*MARVELL IS SAID IN ADVANCED TALKS TO BUY LUMENTUM HOLDINGS $LITE
$GEN might actually be a pretty good business https://t.co/5dQEvZFVwa https://t.co/ewNvBnvYV7
$CVNA looks like it's sacrificing loan monetization to drive units. This is a very slippery slope my friends. We've been short this, and 100% wrong, to be transparent and accountable. But the fundamental story looks like its starting to show signs of erosion on the margin.
Oracle rose about 12% intraday on October 28, 2026 as AI infrastructure and cloud-demand sentiment improved and credit-spread concerns…
Group 1 Automotive trades at 5.5 times earnings as aging gasoline vehicles and EV repairs sustain service profits; insiders bought while…
Cerebras relies on OpenAI for almost all of its $25 billion backlog while renting AI capacity, raising questions over its semiconductor…
Danaher’s new CEO paired a Q3 beat and raised EPS outlook with a 2027 4%-5% organic-growth starting point, while pitching AI-enabled…
Cigna faces PBM margin pressure as employer fee demands and Signature transition costs outweigh specialty-drug growth, limiting profit…
Vertiv beat Q3 revenue guidance by $460 million, grew organic sales 55%, and raised full-year revenue guidance by $650 million to a $14.65…
Alibaba's $100 valuation discounts cloud growth, China competition and US investment-ban risk, while its cloud unit posted 45% revenue…
Innodata shares fell 25% to $44.74 after India Today reported 550 job cuts in India.
GFL’s take-private structure hinges on BC Partners rolling 60% of its stake to preserve debt portability under the 40% permitted-holder…
Lumentum’s 2027 optical-chip expansion, 200G EML and CW capacity, silicon-photonics roadmap, pricing and 3.2T module prospects face…
Public restaurant chains report easing commodity inflation, 3-5% labor inflation and 3-10% unit growth, while digital, delivery and…
Talen’s post-bankruptcy nuclear assets, FREIT’s $22 Kushner bid and Calithera’s failed liquidation vote illustrate unusual small-cap…
Nuveen municipal-bond closed-end funds could unlock illiquid Energy Harbor holdings through Vistra’s acquisition, receiving cash and a…
Essex Biotechnology trades at 8 times earnings despite patented Chinese biologics, near-60% niche market share and a portfolio built with…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.